Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 3
2005 5
2006 10
2007 8
2008 8
2009 9
2010 19
2011 26
2012 9
2013 11
2014 8
2015 13
2016 10
2017 13
2018 8
2019 13
2020 17
2021 9
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

188 results
Results by year
Filters applied: . Clear all
Page 1
Epigenetics of malignant melanoma.
Moran B, Silva R, Perry AS, Gallagher WM. Moran B, et al. Among authors: gallagher wm. Semin Cancer Biol. 2018 Aug;51:80-88. doi: 10.1016/j.semcancer.2017.10.006. Epub 2017 Oct 23. Semin Cancer Biol. 2018. PMID: 29074395 Review.
Effects of HER Family-targeting Tyrosine Kinase Inhibitors on Antibody-dependent Cell-mediated Cytotoxicity in HER2-expressing Breast Cancer.
Collins DM, Madden SF, Gaynor N, AlSultan D, Le Gal M, Eustace AJ, Gately KA, Hughes C, Davies AM, Mahgoub T, Ballot J, Toomey S, O'Connor DP, Gallagher WM, Holmes FA, Espina V, Liotta L, Hennessy BT, O'Byrne KJ, Hasmann M, Bossenmaier B, O'Donovan N, Crown J. Collins DM, et al. Among authors: gallagher wm. Clin Cancer Res. 2021 Feb 1;27(3):807-818. doi: 10.1158/1078-0432.CCR-20-2007. Epub 2020 Oct 29. Clin Cancer Res. 2021. PMID: 33122343 Free PMC article.
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.
DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, Madden SF, Gallagher WM, Wadhwani N, Keil SD, Junaid SA, Rugo HS, Hwang ES, Jirström K, West BL, Coussens LM. DeNardo DG, et al. Among authors: gallagher wm. Cancer Discov. 2011 Jun;1(1):54-67. doi: 10.1158/2159-8274.CD-10-0028. Epub 2011 Jun 1. Cancer Discov. 2011. PMID: 22039576 Free PMC article.
Focus on cancer proteomics.
Collins BC, Gallagher WM. Collins BC, et al. Among authors: gallagher wm. Proteomics. 2012 Jul;12(13):2065-6. doi: 10.1002/pmic.201270084. Proteomics. 2012. PMID: 22807453 No abstract available.
miRNA dysregulation in breast cancer.
Mulrane L, McGee SF, Gallagher WM, O'Connor DP. Mulrane L, et al. Among authors: gallagher wm. Cancer Res. 2013 Nov 15;73(22):6554-62. doi: 10.1158/0008-5472.CAN-13-1841. Epub 2013 Nov 7. Cancer Res. 2013. PMID: 24204025 Free article. Review.
Prognostic and predictive biomarkers in melanoma: an update.
Foth M, Wouters J, de Chaumont C, Dynoodt P, Gallagher WM. Foth M, et al. Among authors: gallagher wm. Expert Rev Mol Diagn. 2016;16(2):223-37. doi: 10.1586/14737159.2016.1126511. Epub 2015 Dec 22. Expert Rev Mol Diagn. 2016. PMID: 26620320 Review.
Truncated HER2: implications for HER2-targeted therapeutics.
Zagozdzon R, Gallagher WM, Crown J. Zagozdzon R, et al. Among authors: gallagher wm. Drug Discov Today. 2011 Sep;16(17-18):810-6. doi: 10.1016/j.drudis.2011.06.003. Epub 2011 Jun 16. Drug Discov Today. 2011. PMID: 21704182 Review.
188 results